Daniel Dengrove
Corporate VC investor in San Francisco
Invests in AIAI is one of the sectors on Daniel Dengrove's investor profile, next to Biotech & Pharma, at seed, early-stage venture and Series A. No deals are on record yet, so this page lists the startup credits a company at these stages can claim.
Email InvestorCredits to line up before a seed round
Daniel Dengrove backs companies at seed, early-stage venture and Series A. A few of the larger credit programs on AI Perks for teams at that point:
Investment focus
- Backs startups in
- Artificial Intelligence, Biotech & Pharma
- Rounds
- Seed, Early-stage venture, Series A
- Profile
- Corporate VC investor
- Deals on record
- None yet
- Based in
- San Francisco, United States

Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Jeff RichAngel investor in Redmond
- Laura ChauGeneral Partner at Canaan
- Eric RiesAngel investor in San Francisco
- Ting GooteeAngel investor in Indianapolis
- Jing WuInvestor and Advisor at InfStones
- Curtis ObergVenture investor in New York City
- Marc SingerManaging Partner at Osage University Partners (OUP)
- Bryan RobertsPartner at Venrock
Questions founders ask
- Does Daniel Dengrove invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Daniel Dengrove's investor profile, together with Biotech & Pharma. The stages on record are seed, early-stage venture and Series A.
- What credits can a startup claim before pitching Daniel Dengrove?
- For a company raising a seed round, AI Perks lists credits such as JetBrains (up to $100,000), Amazon Bedrock (up to $200,000), Neo4j (up to $16,000) and Oracle (up to $10,000), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal